Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480016 | SCV000567193 | pathogenic | not provided | 2023-08-14 | criteria provided, single submitter | clinical testing | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 8090769) |
3billion | RCV002250636 | SCV002521053 | pathogenic | X-linked agammaglobulinemia with growth hormone deficiency | 2022-05-22 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. The variant has been reported to be associated with BTK related disorder (ClinVar ID: VCV000419415). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Institute of Medical Genetics and Applied Genomics, |
RCV004720259 | SCV005328347 | likely pathogenic | X-linked agammaglobulinemia | 2024-09-25 | criteria provided, single submitter | clinical testing |